These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 24921956)
21. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city]. Mouchabac S; Ferreri M; Cabanac F; Bitton M Encephale; 2003; 29(5):438-44. PubMed ID: 14615693 [TBL] [Abstract][Full Text] [Related]
22. Current treatment options: relief of symptoms and ultimate recovery. Kennedy SH Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():22-6. PubMed ID: 24931540 [TBL] [Abstract][Full Text] [Related]
23. Guidelines in major depressive disorder, and their limitations. Montgomery SA Int J Psychiatry Clin Pract; 2006; 10 Suppl 3():3-9. PubMed ID: 24921956 [TBL] [Abstract][Full Text] [Related]
24. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram]. Favré P Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728 [TBL] [Abstract][Full Text] [Related]
26. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566 [TBL] [Abstract][Full Text] [Related]
27. [Severe forms of depression: the efficacy of escitalopram]. Spadone C Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384 [TBL] [Abstract][Full Text] [Related]
28. Escitalopram for the treatment of major depression and anxiety disorders. Höschl C; Svestka J Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657 [TBL] [Abstract][Full Text] [Related]